1.
Deprest, J. et al. In case you missed it: the  editors bring you the most significant advances of 2015. Prenatal Diagnosis 36, 3–9 (2016).
2.
Smith, N. C., Smith, A. P. M. & Smith, N. C. Obstetric and gynaecological ultrasound made easy. (Elsevier Churchill Livingstone, 2006).
3.
Fetal medicine: basic science and clinical practice. (Elsevier, 2020).
4.
Sadler, T. W. Langman’s medical embryology. (Wolters Kluwer, 2015).
5.
Baillière’s Clinical Obstetrics and Gynaecology. 1, (1987).
6.
Genetic Disorders and the Fetus. (John Wiley & Sons Ltd., 2021). doi:10.1002/9781119676980.
7.
Simpson, J. L. & Elias, S. Essentials of prenatal diagnosis. (Churchill Livingstone, 1993).
8.
Harrison, M. R., Golbus, M. S., Filly, R. A. & Harrison, M. R. The unborn patient: the art and science of fetal therapy. (Saunders, 2001).
9.
Chudleigh, P. & Thilaganathan, B. Obstetric ultrasound: how, why and when. (Elsevier Churchill Livingstone, 2004).
10.
Abramsky, L. & Chapple, J. Prenatal diagnosis: the human side. (Nelson Thornes, 2003).
11.
International Society for Prenatal Diagnosis. Prenatal diagnosis. Wiley medical publication,.
12.
International Fetal Medicine and Surgery Society. Fetal diagnosis and therapy.
13.
European Society of Human Genetics. European journal of human genetics: EJHG.
14.
Journal of Prenatal Medicine.
15.
PloS one.
16.
American Association for Clinical Chemistry. Clinical chemistry.
17.
Journal of Medical Ethics. (1975).
18.
Massachusetts Medical Society. The New England journal of medicine.
19.
Wald, N. J. & Bestwick, J. P. Performance of antenatal reflex DNA screening for Down’s syndrome. Journal of Medical Screening 22, 168–174 (2015).
20.
nipd_june_2016.pdf.
21.
Chitty, L. S., van der Schoot, C. E., Hahn, S. & Avent, N. D. SAFE—TheSpecial Non-invasiveAdvances inFetal and NeonatalEvaluation Network: aims and achievements. Prenatal Diagnosis 28, 83–88 (2008).
22.
Wright, C. F. & Burton, H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Human Reproduction Update 15, 139–151 (2008).
23.
Hill, M., Barrett, A. N., White, H. & Chitty, L. S. Uses of cell free fetal DNA in maternal circulation. Best Practice & Research Clinical Obstetrics & Gynaecology 26, 639–654 (2012).
24.
Sparks, A. B., Wang, E. T., Struble, C. A., & Et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis 32, 3–9 (2012).
25.
Barrett, A. N., McDonnell, T. C. R., Chan, K. C. A. & Chitty, L. S. Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia. Clinical Chemistry 58, 1026–1032 (2012).
26.
Bianchi, D. W., Platt, L. D., Goldberg, J. D., & Et al. Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing. Obstetrics & Gynecology 119, 890–901 (2012).
27.
Ravitsky, V. Non-invasive prenatal diagnosis: an ethical imperative. Nature Reviews Genetics 10, 733–733 (2009).
28.
Benn, P. A. Practical and Ethical Considerations of Noninvasive Prenatal Diagnosis. JAMA 301, (2009).
29.
Deans, Z., Clarke, A. J. & Newson, A. J. For Your Interest? The Ethical Acceptability of Using Non-Invasive Prenatal Testing to Test ‘Purely for Information’. Bioethics 29, 19–25 (2015).
30.
Agathokleous, M., Chaveeva, P., Poon, L. C. Y., & Et al. Meta-analysis of second-trimester markers for trisomy 21. Ultrasound in Obstetrics & Gynecology 41, 247–261 (2013).
31.
Celik, E., To, M., Poon, L. C. Y., & Et al. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound in Obstetrics and Gynecology 31, 549–554 (2008).
32.
Gallo, D., Poon, L. C., Fernandez, M., & Et al. Prediction of Preeclampsia by Mean Arterial Pressure at 11-13 and 20-24 Weeks’ Gestation. Fetal Diagnosis and Therapy 36, 28–37 (2014).
33.
Gallo, D. M., Poon, L. C., Akolekar, R., & Et al. Prediction of Preeclampsia by Uterine Artery Doppler at 20-24 Weeks’ Gestation. Fetal Diagnosis and Therapy 34, 241–247 (2013).
34.
Nicolaides, K. H. Turning the Pyramid of Prenatal Care. Fetal Diagnosis and Therapy 29, 183–196 (2011).
35.
Syngelaki, A., Chelemen, T., Dagklis, T., & Et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenatal Diagnosis 31, 90–102 (2011).
36.
Syngelaki, A., Pergament, E., Homfray, T., & Et al. Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities. Fetal Diagnosis and Therapy 35, 174–184 (2014).
37.
Alessandra Cacciatore. Obstetric management in Rh alloimmunizated pregnancy. Journal of Prenatal Medicine 3, (2009).